Literature DB >> 32097457

Stem cell donors should not be screened for clonal hematopoiesis.

Christopher J Gibson1, R Coleman Lindsley1.   

Abstract

This article has a companion Point by DeZern and Gondek.
© 2020 by The American Society of Hematology.

Entities:  

Mesh：

Year:  2020        PMID： 32097457      PMCID： PMC7042999          DOI： 10.1182/bloodadvances.2019000395

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


  29 in total

Review 1.  Concise Review: Age-Related Clonal Hematopoiesis: Stem Cells Tempting the Devil.

Authors:  Lambert Busque; Manuel Buscarlet; Luigina Mollica; Ross L Levine
Journal:  Stem Cells       Date:  2018-06-08       Impact factor: 6.277

2.  Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.

Authors:  Mareike Frick; Willy Chan; Christopher Maximilian Arends; Raphael Hablesreiter; Adriane Halik; Michael Heuser; David Michonneau; Olga Blau; Kaja Hoyer; Friederike Christen; Joel Galan-Sousa; Daniel Noerenberg; Verena Wais; Michael Stadler; Kenichi Yoshida; Johannes Schetelig; Esther Schuler; Felicitas Thol; Emmanuelle Clappier; Maximilian Christopeit; Francis Ayuk; Martin Bornhäuser; Igor Wolfgang Blau; Seishi Ogawa; Tomasz Zemojtel; Armin Gerbitz; Eva M Wagner; Bernd M Spriewald; Hubert Schrezenmeier; Florian Kuchenbauer; Guido Kobbe; Markus Wiesneth; Michael Koldehoff; Gérard Socié; Nicolaus Kroeger; Lars Bullinger; Christian Thiede; Frederik Damm
Journal:  J Clin Oncol       Date:  2018-11-07       Impact factor: 44.544

3.  Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias.

Authors:  Christopher J Gibson; James A Kennedy; Sarah Nikiforow; Frank C Kuo; Edwin P Alyea; Vincent Ho; Jerome Ritz; Robert Soiffer; Joseph H Antin; R Coleman Lindsley
Journal:  Blood       Date:  2017-04-26       Impact factor: 22.113

4.  Age-related clonal hematopoiesis associated with adverse outcomes.

Authors:  Siddhartha Jaiswal; Pierre Fontanillas; Jason Flannick; Alisa Manning; Peter V Grauman; Brenton G Mar; R Coleman Lindsley; Craig H Mermel; Noel Burtt; Alejandro Chavez; John M Higgins; Vladislav Moltchanov; Frank C Kuo; Michael J Kluk; Brian Henderson; Leena Kinnunen; Heikki A Koistinen; Claes Ladenvall; Gad Getz; Adolfo Correa; Benjamin F Banahan; Stacey Gabriel; Sekar Kathiresan; Heather M Stringham; Mark I McCarthy; Michael Boehnke; Jaakko Tuomilehto; Christopher Haiman; Leif Groop; Gil Atzmon; James G Wilson; Donna Neuberg; David Altshuler; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2014-11-26       Impact factor: 91.245

5.  Current Use and Trends in Hematopoietic Cell Transplantation in the United States.

Authors:  Anita D'Souza; Stephanie Lee; Xiaochun Zhu; Marcelo Pasquini
Journal:  Biol Blood Marrow Transplant       Date:  2017-06-09       Impact factor: 5.742

6.  Misdiagnosis of Li-Fraumeni Syndrome in a Patient With Clonal Hematopoiesis and a Somatic TP53 Mutation.

Authors:  Rachel L Mitchell; Cory Kosche; Kelly Burgess; Shreya Wadhwa; Lela Buckingham; Ritu Ghai; Jacob Rotmensch; Oleksandra Klapko; Lydia Usha
Journal:  J Natl Compr Canc Netw       Date:  2018-05       Impact factor: 11.908

7.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.

Authors:  Siddhartha Jaiswal; Pradeep Natarajan; Alexander J Silver; Christopher J Gibson; Alexander G Bick; Eugenia Shvartz; Marie McConkey; Namrata Gupta; Stacey Gabriel; Diego Ardissino; Usman Baber; Roxana Mehran; Valentin Fuster; John Danesh; Philippe Frossard; Danish Saleheen; Olle Melander; Galina K Sukhova; Donna Neuberg; Peter Libby; Sekar Kathiresan; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2017-06-21       Impact factor: 91.245

8.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.

Authors:  Kristian Cibulskis; Michael S Lawrence; Scott L Carter; Andrey Sivachenko; David Jaffe; Carrie Sougnez; Stacey Gabriel; Matthew Meyerson; Eric S Lander; Gad Getz
Journal:  Nat Biotechnol       Date:  2013-02-10       Impact factor: 54.908

9.  Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.

Authors:  Terrence N Wong; Giridharan Ramsingh; Andrew L Young; Christopher A Miller; Waseem Touma; John S Welch; Tamara L Lamprecht; Dong Shen; Jasreet Hundal; Robert S Fulton; Sharon Heath; Jack D Baty; Jeffery M Klco; Li Ding; Elaine R Mardis; Peter Westervelt; John F DiPersio; Matthew J Walter; Timothy A Graubert; Timothy J Ley; Todd Druley; Daniel C Link; Richard K Wilson
Journal:  Nature       Date:  2014-12-08       Impact factor: 49.962

10.  Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults.

Authors:  Andrew L Young; Grant A Challen; Brenda M Birmann; Todd E Druley
Journal:  Nat Commun       Date:  2016-08-22       Impact factor: 14.919
View more
  5 in total

Review 1.  Exploring the Associations Between Clonal Hematopoiesis of Indeterminate Potential, Myeloid Malignancy, and Atherosclerosis.

Authors:  Juan Bautista Menendez-Gonzalez; Neil P Rodrigues
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Clonal Hematopoiesis: From Mechanisms to Clinical Intervention.

Authors:  Thomas Köhnke; Ravindra Majeti
Journal:  Cancer Discov       Date:  2021-12-01       Impact factor: 38.272

Review 3.  Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-09-01       Impact factor: 3.122

Review 4.  What to tell your patient with clonal hematopoiesis and why: insights from 2 specialized clinics.

Authors:  David P Steensma; Kelly L Bolton
Journal:  Blood       Date:  2020-10-01       Impact factor: 25.476

Review 5.  Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia.

Authors:  Sarah S Burns; Reuben Kapur
Journal:  Stem Cell Reports       Date:  2020-08-11       Impact factor: 7.765
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.